OSD
At Recipharm, we understand that risk analysis, formulation and process development all play crucial roles in achieving your quality target product profile (QTPP), regardless of whether it is a new chemical entity (NCE) or generic.
Our formulation development scientists are equipped to create a stable and bioavailable drug product that meets your defined the desired QTPP.
A forward-thinking approach to effective product development
We use a design of experiments (DoE) approach to both formulation development and process development. We systematically explore the impact of formulation factors on product performance, and the effect of key process parameters on manufacturing efficiency, before we begin our work.
DoE is a powerful tool to aid in optimising formulations and processes, minimising drug development risks at the earliest stage of the NPI process, and enhancing efficiency during scale-up from bench to clinic to commercial. This ensures that quality is built in from the beginning, enabling us to ensure your product meets its QTTP.
Our NPI labs are GMP-compliant and can support manufacturing of both clinical trial and commercial materials. With a strong project management team, we are committed to delivering according to strict customer timelines.
Are you interested in our product development offering?
Our goal is to help you develop your products swiftly, minimising complexity so you can get your product to market as quickly as possible. Count on us at every stage of your product development journey.
Contact our experienced team to learn how we can work together.